SHANE MILLARD: Open Payments
NPI 1568444941 · KAILUA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 22 payments from 7 companies in 2025. Trend: 2023 $392 · 2024 $582 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $185 |
| ABBVIE INC. | 7 | $167 |
| Novo Nordisk Inc | 3 | $154 |
| Gilead Sciences, Inc. | 1 | $35 |
| PFIZER INC. | 1 | $23 |
| Exact Sciences Corporation | 1 | $22 |
| Bard Peripheral Vascular, Inc. | 1 | $21 |
Products named: AIRSUPRA, Ozempic, VRAYLAR, UBRELVY, PAXLOVID, The Cologuard Plus Collection Kit, QULIPTA, Mission.
Industry payments across HI — which companies pay providers there.
